Lorcaserin Extended-Release Tablets and Von willebrand factor recombinant Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Vonvendi
- Lorcaserin Extended-Release Tablets-Vopac
- Lorcaserin Extended-Release Tablets-Vopac MDS
- Lorcaserin Extended-Release Tablets-Vorapaxar
- Lorcaserin Extended-Release Tablets-Vorapaxar Sulfate
- Lorcaserin Extended-Release Tablets-Voraxaze
- Von willebrand factor recombinant Intravenous-Lorcaserin Hydrochloride
- Von willebrand factor recombinant Intravenous-Lorcaserin Tablets
- Von willebrand factor recombinant Intravenous-Lorcet
- Von willebrand factor recombinant Intravenous-Lorcet Plus
- Von willebrand factor recombinant Intravenous-Lorcet Tablets
- Von willebrand factor recombinant Intravenous-Lorlatinib